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The clinical microbiology laboratory has historically been considered “low-tech”, especially when 19 
compared to the clinical chemistry laboratory.  However, systems are emerging for the clinical 20 
microbiology laboratory with the potential to automate almost all areas of testing, including inoculation 21 
of primary culture plates, detection of growth on culture media, identification of microorganisms, 22 
susceptibility testing, and extraction and detection of nucleic acids in clinical specimens.  As a result, the 23 
workflow in the microbiology laboratory is changing at a rapid pace and microbiologists have the 24 
challenge of selecting the most appropriate, clinically useful, and cost-effective automation for their 25 
laboratories.  We have asked four experts in this field, from clinical microbiology laboratories in the 26 
United States and Europe, as well as from industry, to comment on the feasibility and impact of 27 
automation in the clinical microbiology laboratory.   28 
 29 
Are you currently using or do you anticipate using an automation platform in 30 
your microbiology laboratory?  If yes, which sections of your laboratory are 31 
automated?   32 
Robin Patel:  Mayo Clinic’s clinical microbiology laboratory has been performing testing since 1911. 33 
Although select tests today resemble those performed a century ago, we have many examples of 34 
automated, state-of-the-art tests. These include blood cultures, infectious diseases serologic platforms 35 
and nucleic acid and proteomic diagnostics, to name a few. For over two decades, microbiology 36 
laboratories have been using automated blood culture instruments that “sense” microbial growth in 37 
blood culture bottles and “flag” positive bottles for immediate attention by laboratory technologists. 38 
Prior to the availability of such systems (in the not-so-distant past), laboratory technologists manually 39 
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evaluated each blood culture bottle on multiple occasions. Technologists today could not fathom 40 
returning to the manual approach used a mere three decades ago. As with many chemistry tests, a 41 
myriad of infectious diseases serologic tests are performed on automated platforms. Nucleic acid 42 
diagnostics, which have been used in our laboratory for over two decades, are evolving to automated, 43 
“black-box”-type formats. We use a core nucleic acid extraction facility preparatory to downstream 44 
molecular microbiology testing. And, several of our nucleic acid amplification platforms are fully 45 
automated. Finally, matrix assisted laser desorption ionization time of flight mass spectrometry has 46 
revolutionized identification of bacteria and fungi in our laboratory. The success of this automated 47 
platform lies in advances in mass spectrometry and bioinformatics. With its implementation, we have 48 
been able to not only to reduce turn-around-times but also the associated cost of identification of 49 
organisms. 50 
Susan M. Novak:  I direct a high volume laboratory servicing 14 hospitals and >100 clinics in the 51 
southwestern United States where automation is a necessity.  Our integrated health care system 52 
services members in a broad geographic area relying on a centralized reference laboratory for 53 
processing and work up of approximately 4000 microbiology specimens per day.  Our microbiology 54 
laboratory has been automated since 2002 with semi-automated and automated plating 55 
instrumentation.  Greater than 80% of the microbiology specimens arrive at the central laboratory for 56 
processing and plating.  Based on the high specimen volume the decision was made years ago to 57 
capitalize on the economies of scale and allow centralized plating.  This improved the plating quality and 58 
mitigated ergonomic injuries by automating repetitive manual functions.  Specimen processing delay in 59 
the medical centers was another reason our health care system chose to centralize and automate 60 
microbiology plating.  Our laboratory is anticipated to expand over the next several years.  This 61 
expansion and increased testing volume will continue to put us in the position to incorporate additional 62 
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automation into the laboratory setting to continue to meet the goal of cost effective quality laboratory 63 
testing.   64 
Gilbert Greub:  Given the current shortage of financial resources and the concomitant increase in 65 
activity of our clinical diagnostic microbiology laboratory of about 4 to 12% per year, we decided to 66 
move towards a fully automated bacteriology laboratory. We also considered automation a priority for 67 
our serological and molecular diagnostic laboratories. Given the ease to automatically handle samples 68 
received in a liquid format, automation of serological laboratories is relatively straightforward. The same 69 
is true regarding molecular diagnostic laboratories, as soon as the first steps of DNA extraction have 70 
been done.  Thus, in our molecular diagnostic laboratory, we now use automation for most DNA 71 
extraction and PCRs.  Automation of PCR was associated with (i) reduced technician workload, (ii) 72 
reduced rate of PCR contamination (< 1%), and (iii) reduced time to results (< 24h).  73 
In our bacteriology laboratory, since fall 2011, we are using an automated inoculation system 74 
which was selected among all systems available at that time based on various criteria including number 75 
and diversity of samples daily received in our laboratory. This system considerably reduces the 76 
technician workload by automatically inoculating and spreading each sample, labeling and sorting  77 
inoculated agar plates and  preparing smears for Gram staining.  For microbial identification we 78 
currently use two stand-alone automated systems. In 2015, we will move to a fully automated 79 
laboratory, by adding the missing pieces to the puzzle, i.e. smart incubators, high quality digital imaging, 80 
automated colony picking system and all required transport belts in-between.  81 
Which features or criteria are/would be most important to you when selecting a 82 
laboratory automation system? 83 
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Susan M. Novak:  Based on our experiences there are several equally important features that need to 84 
be considered when selecting laboratory automation.   Specimen volume, mix and timing of specimen 85 
arrival in the laboratory will drive the size of instrumentation, throughput requirements and type of 86 
automation.  Throughput is a very important metric that must be assessed carefully.  The laboratory 87 
automation capacity must parallel and support the overall specimen volume of each individual 88 
laboratory.  In addition to throughput, reliability (mean time to failure) of the automation is extremely 89 
important.  If adjustments to staffing are based on the implementation of automation it is extremely 90 
important to have robust instrumentation that has little down time and negative impact on the day to 91 
day work flow.  Excessive down time impacts staffing (i.e. overtime) in addition to turn-around-time and 92 
even the morale of the staff.  Implementation of automation in the laboratory is a complex decision and 93 
the negative effect of a poor decision cannot be stressed enough.  It is important that vendors realize 94 
that they must become partners in helping laboratories work through change management with the 95 
staff as automation is integrated into the laboratory setting.  Employee “buy in” is critical to the success 96 
of a new test or piece of automation.  Other criteria are important and it is advisable for laboratories 97 
considering automation to get input from colleagues that have prior experience.  98 
Robin Patel:  Several issues bear consideration. Cost is paramount – will the system result in increased 99 
or decreased operating costs? Increased costs are associated with instrumentation, reagents and/or 100 
disposables. Automated systems should be green; in other words, reagents and disposables should be 101 
minimal. Decreased costs would primarily be expected to be personnel-related. Laboratory safety is an 102 
important consideration as there may be hazards to laboratory personnel associated with automation, 103 
either as a result of exposure to hazardous microorganisms or dangerous equipment. As bizarre as the 104 
latter may seem, we have had instruments harm laboratory personnel! Space must also be considered – 105 
is there space to accommodate automation (and how much remodeling will be needed)? Automation 106 
5 
 
can “solve” problems in the laboratory. Our technologists and laboratory assistants suffered ergonomic 107 
injuries (e.g., as a result of repeat pipetting), which are avoided with automation. Quality control may be 108 
improved, due to avoidance of human error. The possibility of nucleic acid contamination of molecular 109 
diagnostic assays deserves careful consideration, even in the era of automation. Systems must interface 110 
with electronic medical records for test ordering and result reporting. Volume throughput must be taken 111 
into consideration. Can one system/instrument accommodate the laboratory’s volumes? Are modules 112 
available so that the system can evolve with changing test volumes? Specimen collection containers may 113 
need to be standardized to integrate with automated systems. This seemingly trivial task can be 114 
monumental in a large healthcare setting. Instrument evaluation may not always be feasible with full-115 
laboratory automation, impacting the decision-making process (i.e., should the laboratory adopt a 116 
specific platform). Laboratories will need to address strategies to validate automation. Finally, as 117 
laboratories become more reliant on automation, it will be challenging to deal with system failure (due 118 
to instrument breakdown or lack of availability of disposables). Back-up plans will need to be carefully 119 
considered. We have experienced multiple situations where we have moved all of a certain type of 120 
testing to an automated platform only to experience an inability to utilize the platform due to 121 
instrument failure or lack of availability of required disposables (which are often offered from sole 122 
source suppliers). In such situations, the laboratory may be stranded in terms of testing. Lack of 123 
availability of disposables for commonly used systems may have a substantial impact on healthcare 124 
across the nation and around the world.  125 
 126 
How would automation impact your laboratory operation and workflow?  Will 127 
microbiology laboratories make a shift towards “24 hour microbiology”? 128 
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Robin Patel:  In our experience, automation has dramatic affects in these areas. For each system 129 
adopted, laboratories need to reevaluate operations, workflow, space and staffing assignments. Our 130 
laboratory operates 24/7, so increased automation won’t change our routine operating hours! Over the 131 
next decade, however, I expect to see more automation, including robotic incubation of culture plates, 132 
and automated reading of culture plates, as well as automated identification and antimicrobial 133 
susceptibility testing of colonies growing on plates (i.e., using “colony pickers”). Automation of tedious 134 
tasks will allow reassignment of staff to high value work areas requiring increased use of their 135 
intellectual skills. The microbiology technologist of the future will likely apply some of their expertise via 136 
computer interfaces (rather than handling culture plates one-by-one). 137 
Wm. Michael Dunne, Jr.:  If a tree falls in the forest and no one is there to hear it, does it make a sound? 138 
It follows that the sooner clinically actionable patient results were provided to clinicians, the sooner 139 
appropriate therapy would be administered.  This, in turn, could potentially reduce overall length of 140 
hospitalization with concomitant reduction of patient care costs, risk for nosocomial infection, and 141 
improved outcomes.  Time to results (TTR) can be reduced in a number of ways including the use of 142 
rapid diagnostic platforms (e.g., real-time PCR) or the performance of testing on a more frequent basis.  143 
Automation in microbiology holds the promise of specimen processing on a real-time basis that, when 144 
coupled to rapid diagnostic modalities could significantly reduce TTR and, by inference, generate 145 
positive patient outcomes.  Automation, however, doesn’t mean the system runs by itself. Additional 146 
shifts of operation require personnel support (at least until artificial intelligence algorithms permit 147 
accurate interpretation and processing of cultures in the absence of humans).  If pertinent patient 148 
results are generated and posted on the laboratory information system in the wee hours but not acted 149 
upon by medical personnel, then the opportunity is lost and the additional expense of 24 hour operation 150 
is not realized in terms of patient outcome.  I recall a situation where the laboratory adopted RT-PCR 151 
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screening for MRSA.  Because of the cost of controls, the test was performed once daily in the 152 
afternoon.  Upon further evaluation, the results were not reviewed by infection prevention staff until 153 
the following morning.  If the samples had been plated on MRSA screening media when they were 154 
received, the results were available sooner in many cases with similar performance characteristics and 155 
an isolate for subsequent testing.  This does not necessarily apply to reference laboratory testing where 156 
results are billed directly to clients and the additional workload of off-shift testing generates real 157 
income.  In this case, the decision to offer 24-hour testing is found in the balance sheets where 158 
additional revenues are offset by labor expenditures and operational costs.  In summary, the answer to 159 
this question should be based on at least two options - improved patient outcome and/or improved 160 
laboratory income.  It would be nice if both were realized.   161 
 162 
Gilbert Greub:  A 24/24 7/7 availability of some immunochromatographic tests, some direct microscopic 163 
examination such as blood smear for Plasmodium spp. and of selected PCRs is warranted given the 164 
clinical impact and the added value of short time to results. However, given the painfulness of night 165 
shift, the associated social cost and the relatively low clinical impact of 24/24  7/7 shift for most 166 
microbiology processes, a 24 hour microbiology is not a goal of our core bacteriology laboratory. 167 
Nevertheless, automation will clearly modify our workflow and organization. Since agar plates may be 168 
automatically checked by digital imaging at regular intervals and sterile plates automatically discarded, 169 
time to results is significantly improved, especially if the technician working time is extended for 170 
instance from 6 a.m. to 10 p.m. Moreover, moving towards paperless telebacteriology will be a major 171 
opportunity to improve the working atmosphere by reading agar plates in quiet offices located next but 172 




Is a full-laboratory automation system appropriate for all types of laboratories?  175 
Is there a minimum daily specimen volume required to support an automated 176 
platform?   177 
Wm. Michael Dunne, Jr:  The simple answer is “it depends.”  So what does it depend upon?  1.  178 
Scalability and modularity.  Can an automated microbiology system be appropriately scaled to 179 
accommodate the specimen volume and sample types of individual microbiology laboratories with 180 
associated cost adjustments and the potential to increase throughput at a later date? For example, I 181 
recall an instrument developed in the early 2000’s that would screen 300 urine samples per hour and 182 
generate rudimentary identification and susceptibility data for the samples if positive.  The problem with 183 
this business model was that very few laboratories had volumes to justify purchase of the instrument 184 
and a scaled down version wasn’t available.  The system was also very large and was difficult to get into 185 
the laboratory proper without demolition activities.  So if a one-size-fits-all option is developed by 186 
manufacturers, it might limit the market to very large volume laboratories.  Modularity would also allow 187 
laboratories of various sizes to implement specific units of the system.  2.  Availability of skilled labor.  As 188 
the pipeline of individuals completing training in clinical laboratory science programs at all degree levels 189 
decreases, the competition for their services among laboratories will likely increase with the associated 190 
cost of competitive salaries and benefits (supply and demand).  The reduced availability of a skilled 191 
workforce even in smaller laboratories would likely push the equation in favor of automated systems 192 
such that fewer individuals could handle the workload while devoting more time to interpretation and 193 
other complex processes.  3.  Medical economics.  Labor, I believe, still remains the single most costly 194 
component of any laboratory budget line item so it would be desirable to stabilize and minimize the 195 
effects of rising labor costs and shortages.  Reimbursement should also be considered in the equation 196 
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and I can't help but believe that reimbursement rates from third-party payers and government agencies 197 
won’t be going up any time soon.  4.  Specimen complexity.  Clearly a laboratory that processes several 198 
hundred urine samples per day would be more amenable to automation than one that processes a mix 199 
of complex sample types.  To get back to the question, the answer obviously lies somewhere in between 200 
the office lab that processes 5 throat samples and 10 urine cultures per day and a large university-based 201 
or reference laboratory that evaluates hundreds to thousands of mixed sample type cultures daily.   202 
 203 
Gilbert Greub:  Below a given threshold, the cost of the automated system and its maintenance will 204 
outweigh the benefit in term of hands on time and quality. The minimum daily specimen volume 205 
required to support an automated platform will be different for each platform and cost-effectiveness 206 
studies are warranted to define such cut-off. However, these cost analyses are yet completely lacking 207 
for automated microbiology systems.  For example, when considering the different inoculation systems 208 
currently on the market, it readily appear that they target mid-size laboratories since they may inoculate 209 
as many as 180 to 270 agar plates per hour. Such throughput of these inoculation systems is also 210 
optimal for larger laboratories that generally use several inoculation systems in parallel to ease 211 
workflow organization and to provide the necessary back-up during technical failures.  Automated 212 
systems are optimal when the workflow is continuous, i.e. the efficiency decreases when samples are 213 
processed by batch.  214 
Susan M. Novak:  Because all laboratories are not created equal based on depth and scope of work 215 
performed, I do not believe that full laboratory automation systems will be appropriate for all 216 
laboratories.  Incorporation of full laboratory automation will be highly dependent on specimen volume 217 
and the need to become more efficient in the workplace and reduce FTE’s associated with manual tasks 218 
that can be automated.  I believe the medium to large size laboratories will be able to justify full 219 
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laboratory automation more readily because the purchasing of equipment can be tied to a “return on 220 
investment” relative to the amount of staff needed in the laboratory to perform certain tasks.  Smaller 221 
volume laboratories will perhaps take a modular approach with automation, choosing modules or pieces 222 
of automation that support the laboratory.   In speaking with various vendors of plating instrumentation 223 
platforms, the cut off for a plating instrument appears to be approximately 200 specimens per day.  But 224 
some vendors do believe smaller labs could still use this automation.  That said, given that full 225 
laboratory automation is new to microbiology, each lab must perform an analysis to determine what 226 
automation, if any, would be suitable.    227 
 228 
Do you anticipate that adoption of an automated microbiology platform would 229 
restrict you to using products from one vendor? 230 
Susan M. Novak:  This is a very interesting question and one many laboratories that are considering 231 
automation in microbiology are most likely grappling with.  Today there are several pieces of 232 
automation that have been fixtures in the clinical microbiology laboratory for years (i.e. 233 
identification/susceptibility and blood culture systems).  In some laboratory settings, such as ours, 234 
specimen plating instruments have been incorporated to meet pre-analytical needs.    Because these 235 
instruments are unrelated to one another there has never been the need for connectivity.  The need for 236 
integration all changes with the onset of full laboratory automation.  For example, if plates are 237 
transferred via a conveyor below to a smart incubator with a digital camera and a colony is chosen for  238 
identification or susceptibility testing, the plate must be sent to a piece of equipment that can pick the 239 
colony and inoculate needed materials.  In this scenario, connectivity is a prerequisite to full laboratory 240 
automation.  How will that occur if each piece of automation is from a different vendor?  Just because a 241 
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laboratory chooses pre-analytical plating instruments or a digital incubator should not mean that the 242 
identification/susceptibility instrument would need to be changed or that the laboratory will have the 243 
money to do so.  The question remains will the software on these systems be “open” and can various 244 
instruments from varied manufacturers talk to one another?  If this is not the case then this could place 245 
a huge burden on the laboratory.  Switching out several instruments at once would impact the capital 246 
expenditure and also impact the number of validations that need to be performed when integrating new 247 
equipment into the laboratory setting.   248 
Gilbert Greub:  Adoption of an automated microbiology platform may restrict the use of products 249 
proposed by another vendor. Some companies try to protect their market by proposing automated 250 
system with no or very low compatibility with systems from other manufacturers. Fortunately, the 251 
increasing awareness of clinical microbiologists of the importance of such technical compatibility is 252 
progressively pushing the industry to propose flexible solutions. Moreover, some middleware options 253 
are available that may solve some incompatibilities between different automated systems and between 254 
an automated system and the laboratory information system (LIS).  255 
 256 
In an era of laboratory automation, do you think that “routine” microbiology 257 
will continue to be done by specialized microbiology technologists, or do you 258 
think that generalists and/or chemistry technologists will be involved in this 259 
testing?    260 
Gilbert Greub:  Microbiology laboratories will still need technologists trained in microbiology at several 261 
steps, including microscopy and agar plate interpretation, since these activities will still represent a 262 
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pivotal step governing decision on downstream steps.  With automation, the proportion of repetitive 263 
tasks requiring limited knowledge will decrease whereas specialized tasks will increase, as will the need 264 
for specific skills in information technology (IT).  265 
Wm. Michael Dunne, Jr.: Yes (another hedge!).  On one end of the spectrum, less-complicated 266 
processes i.e., specimen accessioning, loading of samples into automated plating systems, reading and 267 
interpretation of screening media, pulling, subculturing and preparing gram-stains of positive blood 268 
cultures, setting up samples for nucleic acid extraction, antimicrobial susceptibility testing (AST), 269 
identification (including MALDI-TOF) and interpretation of certain culture types (e.g., urine) can be 270 
readily accomplished by well-trained laboratory technicians and generalists.  I am a firm believer, 271 
however, that the correct interpretation of more complicated specimen cultures (respiratory, GU, GI, 272 
nephrostomy urine, CSF, blood, tissue, abscess material, implants, etc.) in the context of relevant patient 273 
information requires more focused training and experience.  This is especially true for the interpretation 274 
of antimicrobial susceptibility testing results.  Heck, I've been a clinical microbiologist for more than 30 275 
years and still run across results that I can’t explain.  That is not to say that generalists and/or clinical 276 
chemistry technologists can't gain this level of experience over time, but it requires guidance and 277 
mentoring.  Automation in microbiology doesn't negate the need for interpretive skills.  On the contrary, 278 
automated systems should enhance the efficacy of microbiology specialists by allowing them to devote 279 
their attention toward problem solving and interpretation of complicated sample results or processes.  280 
Further, automation in microbiology has not yet supplanted the need to explain test results to clinicians 281 
in a clear and knowledgeable manner or to suggest further supplementary testing.  So in my estimation, 282 
it would behoove the fully automated clinical microbiology laboratory to establish a good mix of 283 
microbiology specialists for training, hierarchical result interpretation, and physician interface with 284 
generalists capable of maintaining the accelerated workflow.    285 
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Susan M. Novak:  Clinical laboratory scientist pools are diminishing due to many technologists retiring 286 
and fewer replacements in the workplace due to the elimination of training programs.  I believe that the 287 
microbiology laboratory will continue to evolve and change relative to how it appears today.  Based on 288 
the development of more sophisticated automation and software tools there will be a place for the less 289 
specialized laboratorian in microbiology.  With the advancement of digital microbiology and integrated 290 
software programs perhaps a less skilled laboratorian can review cultures that once required a licensed 291 
technologist.  That said, microbiology will still need to report clinically relevant information to the 292 
provider, since not all bacteria growing from a culture is relevant to the patient condition or illness.  The 293 
specialized microbiologist will still have a place in the laboratory but it is anticipated that the overall mix 294 
will change.  Advances in molecular testing have already resulted in the introduction of moderately 295 
complex instrumentation that is easy to run and can be run by a generalist or chemistry technologist 296 
today lacking microbiology expertise.   297 
 298 
What are the challenges in bringing full-laboratory automation in microbiology 299 
to market?  300 
Wm. Michael Dunne, Jr.:  From my point of view (and, again, factor in 30+ years as a clinical 301 
microbiologist), the primary hurdle to overcome toward total laboratory automation in microbiology is 302 
perception.  Unlike our colleagues in clinical chemistry and hematology who have handled much higher 303 
levels of automation for many years,  clinical microbiology has traditionally been a very tactile, hands-304 
on, interpretive practice that is equal parts art and science.  Converting an analog discipline into a digital 305 
one will require a paradigm shift. The process of evaluating microbial growth by holding plates, touching 306 
colonies with loops and the associated odors (accidentally acquired of course) would be replaced by 307 
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high resolution images displayed on a flat screen monitor and robotic manipulation of colonies using 308 
robotics.  Factors that are driving microbiology in the digital direction include laboratory consolidation 309 
and associated workload, an aging skilled workforce with more folks reaching full-time shell-collecting 310 
age than those entering the profession, and paper-thin margins on reimbursement for services.  It is my 311 
feeling that the conversion to automation is happening at a more rapid pace in Europe, Asia and South 312 
America than it is in the US at the moment but that might change shortly.  To accommodate this trend, a 313 
number of modules have been or will be developed which replicate activities that are currently being 314 
performed manually.  These include specimen processing, incubation, culture evaluation, identification, 315 
antimicrobial susceptibility testing, and result reporting.  The modules supporting each of these 316 
processes must be able to function independently as well as in a coordinated fashion to deliver the 317 
desired results whether laboratories select individual components or purchase the whole shooting 318 
match.  With respect to the latter, laboratories and manufacturers will need to form "partnerships" to 319 
gain the level of trust, support and service necessary to keep the systems operating 24 hours/day.  320 
Simple functions that we currently take for granted in daily operations become complex problems for 321 
engineers in the design process such as handling unusual specimen types, movement of plates and 322 
imaging within an incubator without contamination, processing anaerobic cultures, or even something 323 
as simple as preparing a purity plate for AST.  I could go on but imagine the process of setting up disk 324 
diffusion plates by automation and you get the point.   325 
Another issue that will certainly generate a fair degree of angst for system providers will be the 326 
design of clinical trials to gain regulatory clearance for automated microbiology systems.  What would 327 
be the reference standard, manually processed cultures?  What if the culture evaluation module of an 328 
automated system provides additional sensitivity in terms of positive growth detection such that 329 
specificity appears decreased relative to a manual methods? Should modules be evaluated individually 330 
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or as a complete system? These issues will have to be settled with regulatory agencies prior to the onset 331 
of clinical trials. 332 
To conclude, expanding automation in clinical microbiology is a certainty that will necessitate a 333 
change in skill sets and expertise among microbiologists or laboratorians in the future.  Individuals 334 
coming out of clinical laboratory science programs at any degree level will need to accommodate these 335 
changes.   Other major issues that will need to be addressed with the automation of the microbiology 336 
laboratory include overall capital outlay, minimizing contamination within the system (moulds, 337 
mycobacteria, etc.), instrument maintenance and downtime, and in-house validation processes. 338 
Robin Patel:  Challenges include the varied nature of individual laboratories (sizes, physical layouts, test 339 
menus, etc.), cost, and ever-evolving biology (including emerging antimicrobial resistance and 340 
description of novel infectious agents). Although, chemistry laboratories have enjoyed the benefit of 341 
full-laboratory automation for many years, microbiology laboratories have lagged behind because of 342 
their multiple specimen types with varying viscosities and container types and sizes, and because of the 343 
wide diversity of organisms detected. This variability has hindered the availability of full-laboratory 344 
automation for clinical microbiology laboratories. Technology is rapidly changing and improving, 345 
however, such that automation in increasingly used in clinical microbiology laboratories, and full-346 
laboratory automation is becoming possible. However, challenges remain. Platforms are not yet fully 347 
developed. Laboratories that are early adopters may face availability of newer, “better” options in the 348 
near future, and be “stuck” with “antiquated” platforms (analogous to the ever-changing mobile phone 349 
or computer industry). There may be a perception on the part of laboratory technologists that they will 350 
be “replaced by machines”. My personal perspective is that what will be mainly replaced will be the 351 
uninteresting aspects of the job of the laboratory technologist. I find it hard to imagine a scenario where 352 
laboratories would not need the expertise of experienced, well-trained microbiologists to oversee 353 
microbiology testing. 354 
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What is the impact of automation in clinical microbiology on patient care? 355 
Robin Patel:  This is an area of tremendous potential. Automation may provide expedited patient 356 
results, facilitating prompt diagnosis and treatment and avoidance of unnecessary additional testing and 357 
associated costs. (Although it would be intuited that automation would decrease turnaround time for 358 
patient results, depending on the system design, turnaround time may be increased.) Automation may 359 
increase the availability of results after-hours, necessitating new systems for acting on such results (i.e., 360 
at times when healthcare staff is not traditionally available). Automation may avoid falsely positive or 361 
negative results associated with human error. Automated reading of culture plates may facilitate 362 
recognition of colony growth not appreciated with the naked eye, enabling enhanced sensitivity and 363 
earlier detection. Finally, technologic advances will likely bring testing closer to the patient; I predict that 364 
some automated microbiology tests will move out of the laboratory, in a variety of formats, including 365 
automated patient self-testing (for certain organisms). 366 
Gilbert Greub:  During the last ten years, several innovations in microbiology such as MALDI-TOF MS and 367 
point of care molecular assays have had major impact on patient care, since these new diagnostic 368 
approaches are significantly reducing the time to results. Automation in molecular diagnosis has also 369 
contributed to a significant decrease in turnaround time. Automation in clinical microbiology will also 370 
have some impact on patient care by improving traceability, reproducibility and quality. This is especially 371 
true for automated inoculation system that helps much (i) in term of traceability and (ii) in getting high-372 
quality spreading of the inoculum over the agar plate, with a higher number of isolated colonies that 373 
may be used for downstream identification and characterization. Thus, although the precise impact of 374 
automation on patient care has not yet been precisely assessed, I am convinced that in addition to the 375 
benefit of automation on the laboratory workflow and in avoiding repetitive uninteresting tasks, there is 376 
also some benefit of automation on patient care.  377 
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